Total Payments
$16,986
2024 Payments
$2,854
Companies
42
Transactions
1,061
Medicare Patients
7,597
Medicare Billing
$9.4M
Payment Breakdown by Category
Food & Beverage$16,738 (98.5%)
Education$236.81 (1.4%)
Consulting$10.90 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,738 | 1,053 | 98.5% |
| Education | $236.81 | 7 | 1.4% |
| Consulting Fee | $10.90 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,023 | 114 | $0 (2024) |
| ABBVIE INC. | $1,895 | 128 | $0 (2024) |
| Janssen Biotech, Inc. | $1,835 | 118 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,807 | 131 | $0 (2024) |
| UCB, Inc. | $1,324 | 77 | $0 (2024) |
| Genentech USA, Inc. | $1,076 | 74 | $0 (2024) |
| GlaxoSmithKline, LLC. | $990.70 | 57 | $0 (2024) |
| PFIZER INC. | $775.26 | 56 | $0 (2024) |
| Lilly USA, LLC | $753.56 | 46 | $0 (2024) |
| Horizon Therapeutics plc | $627.28 | 50 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,854 | 148 | ABBVIE INC. ($534.65) |
| 2023 | $2,574 | 120 | Janssen Biotech, Inc. ($398.31) |
| 2022 | $1,992 | 107 | ABBVIE INC. ($286.12) |
| 2021 | $1,647 | 102 | Novartis Pharmaceuticals Corporation ($222.98) |
| 2020 | $1,025 | 69 | Horizon Therapeutics plc ($167.21) |
| 2019 | $2,123 | 154 | Novartis Pharmaceuticals Corporation ($255.08) |
| 2018 | $2,498 | 185 | Genentech USA, Inc. ($316.43) |
| 2017 | $2,273 | 176 | Amgen Inc. ($444.91) |
All Payment Transactions
1,061 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/16/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Analgesic | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $3.93 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $41.17 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/15/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $20.49 | General |
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $39.69 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,043 | 210,775 | $9.3M | $2.7M |
| 2022 | 23 | 1,752 | 151,648 | $5.8M | $2.0M |
| 2021 | 25 | 2,029 | 184,149 | $7.2M | $2.8M |
| 2020 | 26 | 1,773 | 141,044 | $4.6M | $2.0M |
Total Patients
7,597
Total Services
687,616
Medicare Billing
$9.4M
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 51 | 19,475 | $2.2M | $615,693 | 28.5% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 39 | 119,880 | $1.8M | $559,002 | 31.1% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 85 | 45,749 | $1.7M | $487,077 | 28.8% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 31 | 7,690 | $1.6M | $472,547 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 573 | 1,405 | $449,600 | $122,314 | 27.2% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 30 | 4,586 | $412,740 | $121,041 | 29.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 66 | 5,400 | $302,400 | $99,325 | 32.8% |
| J0490 | Injection, belimumab, 10 mg | Office | 2023 | 12 | 3,451 | $427,924 | $87,660 | 20.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 122 | 457 | $153,095 | $41,184 | 26.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 162 | 569 | $94,454 | $24,695 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 139 | 139 | $58,797 | $17,048 | 29.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 70 | 330 | $23,760 | $6,615 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 100 | $22,800 | $6,259 | 27.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 231 | 649 | $10,731 | $5,190 | 48.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 22 | 46 | $9,545 | $2,643 | 27.7% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 47 | 213 | $8,520 | $2,320 | 27.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $5,660 | $1,591 | 28.1% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 47 | 235 | $4,935 | $1,524 | 30.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 82 | 125 | $4,500 | $1,254 | 27.9% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 26 | 26 | $2,522 | $687.84 | 27.3% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 41 | 103 | $1,442 | $422.75 | 29.3% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 39 | 96 | $384.00 | $75.60 | 19.7% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 26 | 31 | $62.00 | $15.70 | 25.3% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 47 | 14,950 | $1.7M | $505,237 | 29.9% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2022 | 42 | 94,909 | $1.1M | $440,999 | 38.9% |
About Dr. Gary Gabor, MD
Dr. Gary Gabor, MD is a Rheumatology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437132586.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Gabor, MD has received a total of $16,986 in payments from pharmaceutical and medical device companies, with $2,854 received in 2024. These payments were reported across 1,061 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($16,738).
As a Medicare-enrolled provider, Gabor has provided services to 7,597 Medicare beneficiaries, totaling 687,616 services with total Medicare billing of $9.4M. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Internal Medicine
- Location Jacksonville, FL
- Active Since 11/22/2005
- Last Updated 11/19/2024
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1437132586
Products in Payments
- Enbrel (Biological) $1,352
- Cimzia (Drug) $1,294
- COSENTYX (Biological) $1,266
- BENLYSTA (Biological) $990.70
- RINVOQ (Biological) $931.44
- SIMPONI ARIA (Biological) $792.50
- KRYSTEXXA (Biological) $783.65
- TALTZ (Drug) $661.79
- TREMFYA (Drug) $659.28
- XELJANZ (Drug) $638.43
- ORENCIA (Biological) $613.94
- SAPHNELO (Biological) $600.41
- Rituxan (Biological) $586.54
- Humira (Biological) $519.95
- COSENTYX (Drug) $490.42
- Actemra (Biological) $476.70
- ACTHAR (Biological) $355.42
- KEVZARA (Drug) $333.88
- SKYRIZI (Biological) $293.21
- PURIFIED CORTROPHIN GEL (Drug) $233.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Jacksonville
Gurjit Kaeley, Md, MD
Rheumatology — Payments: $112,066
Rheumatology $112,066
Dr. Swati Shah, Mbbs, MBBS
Rheumatology — Payments: $73,280
Rheumatology $73,280
Dr. Steven Mathews, Md, MD
Rheumatology — Payments: $49,388
Rheumatology $49,388
Andy Abril, Md, MD
Rheumatology — Payments: $20,122
Rheumatology $20,122
Ronald Butendieck, Md, MD
Rheumatology — Payments: $16,596
Rheumatology $16,596
Annabelle Lee, Md, MD
Rheumatology — Payments: $7,883
Rheumatology $7,883